T 1616/17 of 06.12.2021
- European Case Law Identifier
- ECLI:EP:BA:2021:T161617.20211206
- Date of decision
- 6 December 2021
- Case number
- T 1616/17
- Online on
- 24 June 2022
- Petition for review of
- -
- Application number
- 12196725.1
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- AN INHALABLE MEDICAMENT COMPRISING TIOTROPIUM
- Applicant name
- Teva Branded Pharmaceutical Products R&D, Inc.
- Opponent name
- 3M United Kingdom plc
- Board
- 3.3.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 54European Patent Convention Art 56
- Keywords
- Novelty - (yes)
Inventive step - (no) - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.